HomeCompareMTST vs JEPQ

MTST vs JEPQ: Dividend Comparison 2026

MTST yields 333333.33% · JEPQ yields 11.47%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MTST wins by $8.099219044190773e+31M in total portfolio value
10 years
MTST
MTST
● Live price
333333.33%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.099219044190773e+31M
Annual income
$80,944,421,463,343,720,000,000,000,000,000,000,000.00
Full MTST calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.47%
Share price
$53.77
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.8K
Annual income
$2,269.18
Full JEPQ calculator →

Portfolio growth — MTST vs JEPQ

📍 MTST pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMTSTJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MTST + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MTST pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTST
Annual income on $10K today (after 15% tax)
$28,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$68,802,758,243,842,160,000,000,000,000,000,000,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$974.55/yr
After 10yr DRIP, annual income (after tax)
$1,928.80/yr
At 15% tax rate, MTST beats the other by $68,802,758,243,842,160,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTST + JEPQ for your $10,000?

MTST: 50%JEPQ: 50%
100% JEPQ50/50100% MTST
Portfolio after 10yr
$4.0496095220953863e+31M
Annual income
$40,472,210,731,671,860,000,000,000,000,000,000,000.00/yr
Blended yield
99.94%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTST buys
0
JEPQ buys
0
No recent congressional trades found for MTST or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMTSTJEPQ
Forward yield333333.33%11.47%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$8.099219044190773e+31M$45.8K
Annual income after 10y$80,944,421,463,343,720,000,000,000,000,000,000,000.00$2,269.18
Total dividends collected$8.098906375781879e+31M$17.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: MTST vs JEPQ ($10,000, DRIP)

YearMTST PortfolioMTST Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$33,344,033$33,333,333.33$11,967$1,146.53+$33.33MMTST
2$103,911,171,366$103,875,493,250.26$14,216$1,268.02+$103911.16MMTST
3$302,644,656,190,810$302,533,471,237,448.00$16,774$1,392.20+$302644656.17MMTST
4$823,817,797,451,856,400$823,493,967,669,732,100.00$19,667$1,518.21+$823817797451.84MMTST
5$2,095,836,995,961,804,000,000$2,094,955,510,918,530,000,000.00$22,925$1,645.21+$2095836995961804.00MMTST
6$4,983,251,920,823,462,000,000,000$4,981,009,375,237,783,000,000,000.00$26,578$1,772.40+$4983251920823461888.00MMTST
7$11,073,835,968,753,321,000,000,000,000$11,068,503,889,198,040,000,000,000,000.00$30,656$1,899.04+$1.1073835968753322e+22MMTST
8$22,999,277,308,531,336,000,000,000,000,000$22,987,428,304,044,770,000,000,000,000,000.00$35,194$2,024.45+$2.2999277308531335e+25MMTST
9$44,643,905,199,991,210,000,000,000,000,000,000$44,619,295,973,271,085,000,000,000,000,000,000.00$40,228$2,148.01+$4.464390519999121e+28MMTST
10$80,992,190,441,907,720,000,000,000,000,000,000,000$80,944,421,463,343,720,000,000,000,000,000,000,000.00$45,796$2,269.18+$8.099219044190773e+31MMTST

MTST vs JEPQ: Complete Analysis 2026

MTSTStock

MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company's therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.

Full MTST Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this MTST vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTST vs SCHDMTST vs JEPIMTST vs OMTST vs KOMTST vs MAINMTST vs XYLDMTST vs QYLDMTST vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.